Retatrutide is an investigational triple incretin receptor agonist administered as a weekly subcutaneous injection in clinical trials, with dose escalation used to improve tolerability
Fast Food Fast food combines high fat, refined carbs, sodium, and hidden sugars, creating a perfect storm of factors that increase reflux, bloating, nausea, and blood sugar volatility
As a peptidomimetic rather than a true peptide, Dihexa resists gastrointestinal peptidase degradation and crosses the intestinal epithelium
Multiple GLP-1 drugs linked to lower AFib risk GLP-1 receptor agonists (GLP-1-RAs) may be able to reduce a patient's risk of atrial fibrillation (AFib), according to new data presented at Heart Rhythm 2026 in Chicago
If you are losing weight quickly, ask your clinician whether the pace and plan are appropriate
Portraits online marketplace helps med spa owners get solid deals on wellness and weight loss meds, with up to 60% savings